It is expected that by 2026, the market size of recombinant collagen for cosmetics will reach 81 billion yuan ($11.27 billion).

China NMPA released two announcements on valuation principles of recombinant collagen to regulate the development of recombinant collagen.

Giant Biogene released its first financial report since its IPO. The company's revenue in 2022 was 2.364 billion yuan ($343.4 million).